Navigation Links
Insmed Announces First Quarter 2009 Financial Results
Date:5/13/2009

t of product candidates and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2008. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

    Investor Relations Contact:
    Brian Ritchie - FD
    212-850-5683
    brian.ritchie@fd.com

    Media Contact:
    Irma Gomez-Dib - FD
    212-850-5761
    irma.gomez-dib@fd.com


                                INSMED INCORPORATED
                            Consolidated Balance Sheets
                  (in thousands, except share and per share data)
                                               (unaudited)
                                                 March 31,      December 31,
                                                   2009              2008

    Assets
    Current assets:
      Cash, cash equivalents and short-term
       investments                             $127,540            $2,397
      Accounts receivable, net                      114               122
      Prepaid expenses                               30                74
      Total current assets                      127,684             2,593

    Long-term assets:
      Certificate of deposit                      2,085                 -
      Restricted cash, long-term                      -             2,095
      Deferred financing costs, net                  51                70
      Total long-term assets                  
'/>"/>
SOURCE  Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 

Related biology technology :

1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
3. Insmed to Appeal Delisting Notification From Nasdaq
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
7. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
9. Insmed Announces Additional Information in Compliance With NASDAQ Rules
10. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
11. Insmed to Present at CBI Follow-On Biologics Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)Alberta Centre for Advanced Micro Nano Technology Products (ACAMP) hosts, health & medical seminar, , EDMONTON, Dec. 4 /PRNewswire/ - Today ACAMP hosted a health & medical seminar, explaini
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)HOPKINTON, Mass., Dec. 3 Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 softwa
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
Breaking Biology Technology:Alberta companies delivering new products to the health & medical marketplace 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...the design and manufacturing of circuits at nanosc...f the frontier fields in new material science and ...these devices often is accompanied by new discover...are of extremely small dimensions. Understanding t...me has enabled researchers to study the possibilit...
...tek Biosciences,Corporation (Nasdaq: MATK ) annou...ing Canaccord Adams Healthy Living Conference bein...l in Boston, MA. Pete Buzy, CFO and,David Abramson...rn Time on,Wednesday, October 15., A live audio w...:, http://www.newswire.ca/en/webcast/viewEvent.cgi...
...sualty incidents --,such as terrorist attacks, pan...thquakes or hurricanes -- raise the life-and-death...equate to provide treatment for all who,need it. O...ators for,people requiring respiratory support., ... know that mass,casualty events could mean that:, ...
Other Biology Technology:A new material could act as a nanofridge for microchips 2Allied Healthcare Launches First of Line of Ventilators Designed to Meet Demands of Mass Casualty Incidents 2Allied Healthcare Launches First of Line of Ventilators Designed to Meet Demands of Mass Casualty Incidents 3
(Date:12/3/2009)WALL, N.J., Dec. 3 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced that a majority of its sha
(Date:12/3/2009)Contents of this message: , , Preliminary Press Conference Topics, Last Call! Press Field Trip to California Academy of Sciences museum, Attention PIOs: Sending Press Releases to Fall meeting, N
(Date:12/3/2009)Have you ever felt overly upset by a social snubbing? Your genetics, not your friends, may be at fault. , Scientists have long known that opium-like painkillers, called opioids, relieve not only phys
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6New Insights Could Help Shield Babies From Diarrhea Bug 51939 1New Insights Could Help Shield Babies From Diarrhea Bug 51939 2Blacks Have Highest Obesity Rates in U S 51937 1Blacks Have Highest Obesity Rates in U S 51937 2Blacks Have Highest Obesity Rates in U S 51937 3Arcadian Chairman and Chief Executive Officer Robert Fahlman to Present at Focus on Healthcare Conference in New York City 51935 1
...Amsterdam, 12 November 2008. - Elsevier, a leading...formation products and services, announced today t...Life Sciences ( http://www.elsevier.com/locate/nj...ricultural Sciences (KLV), starting in 2009 with V...f Life Sciences , published since 1952, is the qua...
...A rapid, climate change-induced northern migration...s announced Tues. Nov. 11 during opening day prese...iodiversity, Ciudad de las Artes y las Ciencias, i...species of marine macroalgae spread at 50 km per d... invasive terrestrial plants. The difference may ...
...WEST LAFAYETTE, Ind. - A Purdue University researc...on of the virus that causes SARS and could lead to...SARS in 2003 led to hundreds of deaths and thousan...nt," said Arun Ghosh, the Purdue professor that le...urrently a threat, there is the concern that SARS ...
Other Biology News:Marine invasive species advance 50 km per decade, World Conference on Marine Biodiversity told 2Marine invasive species advance 50 km per decade, World Conference on Marine Biodiversity told 3Marine invasive species advance 50 km per decade, World Conference on Marine Biodiversity told 4Purdue researcher invents molecule that stops SARS 2Purdue researcher invents molecule that stops SARS 3
Mouse Oligodendrocyte Differentiation Kit from R&D Systems
Goat Anti-VAP-1 (S-13) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
...atoms at the 3, 3', 4, and 4' positions. It is int...tification of Prostaglandin E2 (PGE2) by GC- or LC...looxygenase products of arachidonic acid and one o... activity influences inflammation, fertility and p...
Site-directed Mutagenesis from Exon BioSystems
Biology Products: